BioStock: Pila Pharma rounds off first quarter as a publicly traded company
So far, 2021 has been a transformative year for Pila Pharma, and the third quarter was no exception. The company can look back at a period characterised by a publicly traded share, a scientific principle being awarded the Nobel Prize, and preparations for phase II. Shifting its focus on what lies ahead, additional milestones are coming up for Pila Pharma.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se